It uses pragmatic molecular tests to identify ECs with mismatch repair deficiency (MMRd), mutations in the exonuclease domain of DNA polymerase epsilon (POLE), and wild type or aberrant p53 expression (p53 wt or p53 abn respectively) [34]. Here, TP53 is linked to mismatch repair cancer syndrome 1.